Loading…
Bruker
BRKR · NASDAQ · Health Care Equipment
BRKR · NASDAQ · Health Care Equipment
Health Care Equipment company based in Billerica, Massachusetts.
In the last 90 days, no insider of Bruker reported an open-market purchase and 4 open-market sales worth about $539K. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$63.86
Last 12 months
Not enough history
Market value
Not available
Revenue
$839M
+5.2% vs the same quarter a year earlier
Free cash flow, last 12 months
$93.9M
This quarter −$106M, a year earlier −$149M
Net debt
$1.64B
Debt $1.82B, cash $185M, at Jun 30, 2026
Backlog
$2.78B
Work contracted but not yet delivered, as the company reports it
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 4, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
4 sales
$539K sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$3.44B
+2.1% vs the year before
Net income, fiscal 2025
−$8.6M
A loss for the year
Shares outstanding
Not available
Reported per share class only, with no single total
In fiscal 2025 the company spent $10M buying back its own shares and $22.8M on dividends. Cash actually paid, from its cash-flow statement.
Stock since the trade +10.7% · S&P 500 +0.3% · to Oct 5
Bruker's President BMID Group sold $198K of Bruker shares. Nobody planned it ahead of time.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last 12 months, adjusted daily closes
Adjusted close went from $36.46 on Oct 6, 2025 to $63.86 on Oct 5, 2026 (+75.2%). Disclosed activity in the last 12 months: 0 insider purchases, 16 insider sales (13 under pre-arranged plans), 0 Congress purchases, 0 Congress sales.
Top officer leaving
“Bernard will step down as CEO and Managing Director once his successor is appointed.”
1 insider sold ~$145K in the 60 days before
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.